🧬 Noam Solomon - Immunai - Part 4 | How Searching for Investors is Like Finding a Life Partner | Luck In Fundraising | The Optimal Features of the Immune System | The Advice to Take More Risks

The Biotech Startups Podcast

As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” on https://www.excedr.com/rewards.
Part 4 of 4.

My guest for this week’s episode is Noam Solomon, CEO and co-founder at Immunai, a pioneering biotech company that is comprehensively mapping and reprogramming the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development, and improve patient outcomes.

Prior to co-founding Immunai, Noam had a career in both industry and academia. Noam has a double PhD in math and computer science and served as a postdoctoral researcher at MIT and Harvard. Noam also worked as an algorithms developer, consultant, and head of data science in several high-tech companies in Israel. Noam's extensive background in math, computer science, AI, and machine learning gives him a unique depth of experience that founders can learn from.

Join us this week and hear about:

• Noam's unique dynamics of working with academic institutions and the alignment of incentives that come with collaborating with top researchers
• The importance of strategic partnerships and the meticulous analysis involved in selecting the right collaborators
• Noam’s fundraising journey
• The technological advancements at Immunai
• The application of AI in optimizing drug development processes

Please enjoy my conversation with Noam Solomon.
Timestamps:

00:00 Intro

01:35 Episode starts, screening for the right business partners and determining what projects to take on and which ones to pass

07:40 Noam’s philosophy and tips on fundraising

15:47 What to expect of Immunai in the next year or two

19:30 Shout outs for help along his journey

21:47 Advice to your 21-year old self

24:15 Outro

Find Our Guest, Noam Solomon, at this link:

https://www.linkedin.com/in/noam-solomon-142393129/

https://www.immunai.com/

Find Our Host, Jon Chee, at these links:

https://www.linkedin.com/in/jonchee

https://www.excedr.com

Social & Website

LinkedIn: https://www.linkedin.com/company/excedr/

Youtube: https://www.youtube.com/@excedr

Instagram: https://www.instagram.com/excedr_inc

Twitter: https://twitter.com/ExcedrInc

Facebook: https://www.facebook.com/excedr

TikTok: https://www.tiktok.com/@excedr

Podcast Website: https://www.thebiotechstartupspodcast.com/

Enriched Notes:

Topics Mentioned:

Biotech Startup Support https://www.excedr.com/resources-category/biotech-startup-support

Biotech Funding for Startups: What Are Your Options? https://www.excedr.com/resources/biotech-startup-funding-options

How to Get Funding for Lab Research in 2024 https://www.excedr.com/blog/how-to-get-funding-for-lab-research

How to Raise Money from Angel Investors https://www.excedr.com/resources/angel-funding-and-angel-investors

What Is Series A, B, & C Funding? Series Funding Explained https://www.excedr.com/resources/series-funding-explained

How to Fund an R&D Startup: First Steps a Founder Can Take https://www.excedr.com/resources/rd-startup-funding-first-steps

Biotech Partnerships: How Partnering with Big Pharma Can Support R&D https://www.excedr.com/blog/how-biotech-partnerships-support-research

What Should Investors & Founders Expect From Each Other? https://www.excedr.com/resources/investor-founder-expectations

People Mentioned

Luis F. Voloch https://www.linkedin.com/in/luisvoloch/

Ansu Satpathy https://www.linkedin.com/in/ansu-satpathy-67a5a9193/

Danny Wells https://www.linkedin.com/in/danny-wells-bb03453a/

Dan Littman https://www.pfizer.com/people/leadership/board-of-directors/dan_littman-md-phd

The Biotech Startups Podcast is handcrafted by our friends over at: fame.so